Belpointe Asset Management’s KeyCorp KEY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Buy
11,972
+269
+2% +$5.86K 0.01% 929
2026
Q1
$235K Buy
11,703
+666
+6% +$14K 0.01% 945
2025
Q4
$228K Buy
11,037
+661
+6% +$12.3K 0.01% 927
2025
Q3
$194K Buy
+10,376
New +$192K 0.01% 938
2023
Q2
Sell
-10,823
Closed -$136K 2049
2023
Q1
$136K Sell
10,823
-3,364
-24% -$56.8K 0.01% 1139
2022
Q4
$247K Buy
14,187
+1,941
+16% +$34.1K 0.01% 797
2022
Q3
$196K Buy
12,246
+7
+0.1% +$125 0.01% 847
2022
Q2
$211K Buy
12,239
+1,364
+13% +$26.4K 0.01% 806
2022
Q1
$243K Buy
10,875
+276
+3% +$6.86K 0.01% 826
2021
Q4
$245K Sell
10,599
-354
-3% -$8.21K 0.02% 813
2021
Q3
$236K Sell
10,953
-899
-8% -$18.2K 0.02% 791
2021
Q2
$245K Buy
11,852
+958
+9% +$20.8K 0.02% 750
2021
Q1
$218K Buy
+10,894
New +$210K 0.02% 714
2020
Q1
Sell
-5,227
Closed -$106K 713
2019
Q4
$106K Buy
+5,227
New +$98.6K 0.01% 765
2019
Q3
Sell
-6,283
Closed -$112K 697
2019
Q2
$112K Buy
+6,283
New +$106K 0.02% 566

Other funds holding KEY

Belpointe Asset Management's KEY Position: Q2 2026 in Review

Belpointe Asset Management increased its KeyCorp (KEY) stake by 2.3% in Q2 2026, buying an estimated $5.86K and bringing the position to 11,972 shares worth $276K. The position accounts for 0.01% of the portfolio, ranked #929.

Belpointe Asset Management first reported a position in KEY in Q2 2019 and has held it in 15 quarters since. 354 funds tracked by Wall St. Rank hold KEY as of Q2 2026.

  • Belpointe Asset Management held 11,972 shares of KeyCorp worth $276K as of Q2 2026.
  • Belpointe Asset Management bought 269 KeyCorp shares in Q2 2026, an estimated $5.86K.
  • KeyCorp made up 0.01% of Belpointe Asset Management's portfolio in Q2 2026, its #929 holding.
  • Belpointe Asset Management first reported a position in KeyCorp in Q2 2019 and has held it in 15 quarters since.
  • 354 funds tracked by Wall St. Rank held KeyCorp as of Q2 2026.

Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.